RXi Pharmaceuticals Corporation (RXII) dropped -5.4% or -0.02 to $0.33. It is near to 2.90 million shares traded, which is 133.82% compare to the average total volume 2.16 million. The market cap of RXII is $2.69 million. The year to date change is -99.03%. The 52 week price range is from $0.31 to $7.7. Price of RXII have changed -20.63% during last week. It have changed -33.88% over last month, -76.79% over last 3 months, -82.74% over last 6 months and -93.18% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 0.78. It is 136.36% above current price. The 200-day Moving Averages for RXII is 2.11. It is 539.39% above current price. The 52-week High is 7.7. It is 2233.33% from the current price. The 52-week Low is 0.31. It is -6.06% from current price.
There are some statistics of RXII. It is has market cap $2.69 million. The share outstanding is 8.13 million. The average volume is 2.16 million. The percent of top 15 Institution holding is 0.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -184.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -117.95%.